[1] Recio R, Perez-Ayala A.Cryptococcus neoformans Meningoencephalitis[J]. The New England Journal of Medicine,2018,379(3):281. [2] Chinese Pharmacopoeia Commission.Instructions for clinical use of the pharmacopoeia of the people's republic of china: volume of chemical medicines and biological products (2010 edition)(中华人民共和国药典临床用药须知:化学药和生物制品卷2020年版)[M]. Beijing:China Medical Science and Technology Press, 2011:798-805. [3] Liu ZY, Wang GQ, Zhu LP, et al.Expert consensus on the diagnosis and treatment of cryptococcal meningitis[J]. Chin J Intern Med(中华内科杂志),2018,57(5):317-323. [4] Shen YZ.Clinical rational application of liposomal amphotericin B[J].Chin JAntibio(中国抗生素杂志),2015,40(7):495-499. [5] Richard H D.Pharmacology of amphotericin B[EB/OL]. https://so. uptodate.cn/contents/pharmacology-of-amphotericin-b.2018-01-10. [6] Amphotericin B [prescribing information]. Big Flats, NY: X-Gen Pharmaceuticals,Amphotericin B [prescribing information]. Big Flats, NY: X-Gen Pharmaceuticals, April 2010. [7] North China Pharmaceutical Company.Ltd. Amphotericin B for Injection [EB/OL]. (2019-01-24)[2019-06-10]. http://www.ncpc.com/?post_type=product&p=10923 [8] Cheng GW, Li SB, Luo LM, et al.Feasibility of treating cryptococcus neoformans meningitis with intrathecal lipid amphotericin B[J]. Evaluation and Analysis of Drug-Use in Hospitals of China(中国医院用药评价与分析),2008,8(5):382-384. [9] New Asia Pharmaceutical.Amphotericin B liposome for injection [EB/OL].(2016-02-01)[2019-06-10].https://www.xinyapharm.com/antifungalAgents. [10] Srichatrapimuk S, Sungkanuparph S.Integrated therapy for HIV and cryptococcosis[J]. AIDS Res Ther, 2016,13(1):42. [11] FDA. AmBisome (amphotericin B) liposome for injection. Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)-March 2012[EB/OL].[2019-06-10]http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm299520.htm. [12] Richard HD,John RP.Pharmacology of flucytosine (5-FC)[EB/OL]. (2018-01-05)[2019-06-10].https://so.uptodate.cn/contents/pharmacology-offlucytosine-5-fc,. [13] Perfect J R, Dismukes W E, Dromer F, et al.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2010,50(3):291-322. |